Overview

Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study

Status:
Recruiting
Trial end date:
2024-09-01
Target enrollment:
Participant gender:
Summary
This is a multicenter study assessing the efficacy of nivolumab in association with relatlimab.
Phase:
Phase 2
Details
Lead Sponsor:
Institut Bergonié
Collaborator:
Bristol-Myers Squibb
Treatments:
Nivolumab